“Efficacy and Safety of Tralokinumab Treatment in Adults of Different Racial Subgroups With Moderate-to-Severe Atopic Dermatitis in Three Randomized, Placebo-Controlled Phase 3 Trials”. 2022. SKIN The Journal of Cutaneous Medicine 6 (6): s76. https://doi.org/10.25251/skin.6.supp.76.